131 related articles for article (PubMed ID: 37574320)
1. [Application of TIGIT combined with interleukin-6 detection in the evaluation of Crohn's disease status].
Xiao L; Yang JP; Wang W
Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Aug; 57(8):1253-1258. PubMed ID: 37574320
[TBL] [Abstract][Full Text] [Related]
2. [T lymphocyte subsets combined with inflammatory indicators for auxiliary diagnosis and prognosis evaluation of sepsis].
Li FF; Yang L; Wang DQ; He WJ; Wang C; Mu H
Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Apr; 56(4):494-502. PubMed ID: 35488549
[No Abstract] [Full Text] [Related]
3. Clinical Remission of Sight-Threatening Non-Infectious Uveitis Is Characterized by an Upregulation of Peripheral T-Regulatory Cell Polarized Towards T-bet and TIGIT.
Gilbert RM; Zhang X; Sampson RD; Ehrenstein MR; Nguyen DX; Chaudhry M; Mein C; Mahmud N; Galatowicz G; Tomkins-Netzer O; Calder VL; Lightman S
Front Immunol; 2018; 9():907. PubMed ID: 29774027
[TBL] [Abstract][Full Text] [Related]
4. Elevated Expression of Immunoreceptor Tyrosine-Based Inhibitory Motif (TIGIT) on T Lymphocytes is Correlated with Disease Activity in Rheumatoid Arthritis.
Luo Q; Deng Z; Xu C; Zeng L; Ye J; Li X; Guo Y; Huang Z; Li J
Med Sci Monit; 2017 Mar; 23():1232-1241. PubMed ID: 28282368
[TBL] [Abstract][Full Text] [Related]
5. Study on the correlation and clinical significance of T-lymphocyte Subsets, IL-6 and PCT in the severity of patients with sepsis.
Li Q; Yan W; Liu S; Li H
Pak J Med Sci; 2023; 39(1):227-231. PubMed ID: 36694784
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of lymphocyte subsets and cytokine profiles of patients with COVID-19.
Pan P; Du X; Zhou Q; Cui Y; Deng X; Liu C; Hu Z; Chen J; Yu X; Shi W
Virol J; 2022 Mar; 19(1):57. PubMed ID: 35346253
[TBL] [Abstract][Full Text] [Related]
7. Reference ranges of lymphocyte subsets in healthy adults and adolescents with special mention of T cell maturation subsets in adults of South Florida.
Valiathan R; Deeb K; Diamante M; Ashman M; Sachdeva N; Asthana D
Immunobiology; 2014 Jul; 219(7):487-96. PubMed ID: 24661720
[TBL] [Abstract][Full Text] [Related]
8. Interleukin 16 expression and phenotype of interleukin 16 producing cells in Crohn's disease.
Middel P; Reich K; Polzien F; Blaschke V; Hemmerlein B; Herms J; Korabiowska M; Radzun HJ
Gut; 2001 Dec; 49(6):795-803. PubMed ID: 11709514
[TBL] [Abstract][Full Text] [Related]
9. [Association of Breg cells and Treg cells with the clinical effects of Infliximab in the treatment of Chinese patients with Crohn's disease].
Lin QR; Xia XP; Cai XN; Hu DY; Shao XX; Xia SL; Jiang Y
Zhonghua Yi Xue Za Zhi; 2020 Nov; 100(42):3303-3308. PubMed ID: 33202491
[No Abstract] [Full Text] [Related]
10. Visceral adiposity and inflammatory bowel disease.
Rowan CR; McManus J; Boland K; O'Toole A
Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
[TBL] [Abstract][Full Text] [Related]
11. Relationships of circulating CD4
Duclaux-Loras R; Boschetti G; Flourie B; Roblin X; Leluduec JB; Paul S; Almeras T; Ruel K; Buisson A; Bienvenu J; Josson C; Jasnowski R; Legastelois S; Foussat A; Meunier C; Viret C; Rozieres A; Faure M; Kaiserlian D; Nancey S
Front Immunol; 2022; 13():864353. PubMed ID: 36405740
[TBL] [Abstract][Full Text] [Related]
12. Deficit of gammadelta T lymphocytes in the peripheral blood of patients with Crohn's disease.
Andreu-Ballester JC; Amigó-García V; Catalán-Serra I; Gil-Borrás R; Ballester F; Almela-Quilis A; Millan-Scheiding M; Peñarroja-Otero C
Dig Dis Sci; 2011 Sep; 56(9):2613-22. PubMed ID: 21374064
[TBL] [Abstract][Full Text] [Related]
13. Elevated expression of TIGIT on CD3
Luo Q; Ye J; Zeng L; Li X; Fang L; Ju B; Huang Z; Li J
Allergy Asthma Clin Immunol; 2017; 13():15. PubMed ID: 28261278
[TBL] [Abstract][Full Text] [Related]
14. [Effect of dendritic cells on immune function regulated by programmed cell death-1/programmed cell death-ligand 1 in sepsis].
Wang Z; Xie Z; Zhao Y; Bu T; Yu A; Wang S
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Sep; 33(9):1032-1039. PubMed ID: 34839857
[TBL] [Abstract][Full Text] [Related]
15. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome.
Papadavid E; Economidou J; Psarra A; Kapsimali V; Mantzana V; Antoniou C; Limas K; Stratigos A; Stavrianeas N; Avgerinou G; Katsambas A
Br J Dermatol; 2003 Apr; 148(4):709-18. PubMed ID: 12752128
[TBL] [Abstract][Full Text] [Related]
16. Recovery of CD226-TIGIT
Long Y; Wang C; Xia C; Li X; Fan C; Zhao X; Liu C
Immunol Lett; 2020 Feb; 218():30-39. PubMed ID: 31883787
[TBL] [Abstract][Full Text] [Related]
17. Expanded CD4+CD45RO+ phenotype and defective proliferative response in T lymphocytes from patients with Crohn's disease.
Roman LI; Manzano L; De La Hera A; Abreu L; Rossi I; Alvarez-Mon M
Gastroenterology; 1996 Apr; 110(4):1008-19. PubMed ID: 8612987
[TBL] [Abstract][Full Text] [Related]
18. [Value of interleukin-6 and CD4
Shi X; Qin L; Yang L; Bai W; Jing L; Mei K
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Oct; 32(10):1165-1170. PubMed ID: 33198856
[TBL] [Abstract][Full Text] [Related]
19. T Lymphocyte Activation Markers as Predictors of Responsiveness to Rituximab among Patients with FSGS.
Chan CY; Liu ID; Resontoc LP; Ng KH; Chan YH; Lau PY; Than M; Jordan SC; Lam KP; Yeo WS; Yap HK
Clin J Am Soc Nephrol; 2016 Aug; 11(8):1360-1368. PubMed ID: 27269610
[TBL] [Abstract][Full Text] [Related]
20. [The diagnostic and evaluation value of plasma interleukin 9 in the mucosal healing in patients with inflammatory bowel disease treated with biological agents].
Ye YL; Hu T; Xu LJ; Zhang LP; Yin J; Yu Q; Pang Z
Zhonghua Yi Xue Za Zhi; 2023 May; 103(19):1483-1489. PubMed ID: 37198111
[No Abstract] [Full Text] [Related]
[Next] [New Search]
